Convoke completed $8.6 million Seed Round funding
Sector:
Software
Life Science
AI
08/19/2025
S San Francisco, CA USA
Convoke
completed $8.6 million Seed Round funding. Investors include
Dimension (lead), Kleiner Perkins Caufield and Byers (lead), ACME Capital, Comma Capital, Liquid 2 Ventures, Not Boring Capital, Audacious Ventures, Lux Capital.
"A surprising amount of time is lost to manual, repetitive, or burdensome tasks that could be automated with language model-based systems," said Alex Telford, CEO and co-founder of Convoke. "Our goal with Convoke is to build software that applies recent advances in AI to unlock capacity and increase the 'clock speed' of biopharma organizations."
About
Convoke is the AI-native operating system for biopharma companies, offering software tools that unify internal and external data, codify decision logic, and generate critical deliverables across the drug lifecycle, helping teams move from idea to market faster. Founded by Alex Telford, Maged Ahmed, and Vikas Velagapudi — veterans of the pharmaceutical industry, Applied Intuition, and early-stage healthtech — the company's platform has helped customers rapidly accomplish in-house what once required large teams or costly consultants.
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
